Abstract:Many surface receptors and signaling molecules are thought to associate with unique membrane microdomains termed lipid rafts. We examined the involvement of lipid rafts in the activation of leukocyte function associated antigen (LFA-1). Depletion or sequestration of cholesterol with methyl- (cid:1) -cyclodextrin (MCD) or filipin, respectively, strongly inhibited LFA-1-mediated adhesion of T cell lines and primary T cells. This inhibition was reversed by cholesterol reconstitution. LFA-1 on T cell lines was detected in cold Triton X-100-insoluble lipid rafts, which were disrupted by MCD or filipin treatment. However, no LFA-1 on primary T cells was detected in lipid rafts isolated by the same procedures, and these rafts were resistant to cholesterol depletion or sequestration. Association of LFA-1 with lipid rafts of primary T cells could only be detected when they were isolated with another non-ionic detergent, Brij 35. Upon treatment with MCD, LFA-1 in Brij 35-insoluble lipid rafts partially shifted to non-raft fractions. T cell lines were found to have high level of cholesterol and low level of ganglioside GM1, a common marker for lipid rafts, whereas primary T cells have much lower level of cholesterol and very high amount of GM1. Cross-linking of LFA-1 on primary T cells induced co-capping of cholesterol but not GM1. These results suggest that lipid rafts of T cells are heterogenous and LFA-1 associates with a subset of lipid rafts containing high level of cholesterol. This association seems to regulate LFA-1 functions, possibly by facilitating LFA-1 clustering. cross-linking of CTx of LFA-1. In contrast, confocal microscopic analysis LFA-1 transfected into the human T cell line Jurkat showed that LFA-1 does not associate with rafts unless it is activated by Mn 2+ or the I-domain is deleted from LFA-1. 23 Shamri et al. also reported that cholesterol extraction by MCD does not inhibit LFA-1-mediated adhesion of human peripheral blood T cells to ICAM-1. 24 Thus, studies with different cells and techniques have resulted in conflicting results regarding the association of LFA-1 with lipid rafts and its functional significance. Here we show that cholesterol depletion or sequestration strongly inhibits LFA-1-mediated adhesion of murine T cells. Although cholesterol is thought to be an essential component of lipid rafts in general, our results suggest that lipid rafts of primary T cells are heterogeneous and some lipid rafts seem to contain little cholesterol. LFA-1 is detected in a subset of lipid rafts that are cholesterol-rich and sensitive to MCD treatment. secondary anti-rat Ig antibody. GM1 was detected by horse radish peroxidase-conjugated CTxB.

Membrane cholesterol regulates LFA-1 function and lipid rafts heterogeneity

Rare Presentation of Pulmonary Alveolar Proteinosis Causing Acute Respiratory Failure

Origin of aromatase inhibitory activity via proteochemometric modeling

Current perspectives on aromatase inhibitors in breast cancer

Targeting aromatase to restrain oestrogen production and developing efficacious interventions against ER-positive cancer

Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs

Syntheses and Qsar Studies of Benzylimidazole Derivatives and Benzylcarbazole As Potential Aromatase Inhibitors

Proliferation and collagen production of human patellar tendon fibroblasts in response to cyclic uniaxial stretching in serum-free conditions.

Screening for Aromatase Ligands in the Extract of Broussonetia Papyrifera Using High Performance Liquid Chromatography and ESI-mass Spectrometry

Two Natural Products, Trans-Phytol and (22E)-Ergosta-6,9,22-triene-3β,5α,8α-triol, Inhibit the Biosynthesis of Estrogen in Human Ovarian Granulosa Cells by Aromatase (CYP19)

Two Natural Products, Trans-Phytol And (22e)-Ergosta-6,9,22-Triene-3 Beta,5 Alpha,8 Alpha-Triol, Inhibit The Biosynthesis Of Estrogen In Human Ovarian Granulosa Cells By Aromatase (Cyp19)

Unlocking the potential of aromatase inhibitors: recent advances in drug design, synthesis, docking activity, and in vitro bioactivity evaluations

Synthesis and Modeling of Novel Α-Aminoalkylphosphonate Ester Derivatives As Potent Inhibitors of Prostate-Specific Antigen; A Comparison Study

Design, Synthesis and Activity of Flavonoids Aromatase Inhibitors

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved

Polyphenolic natural products and natural product–inspired steroidal mimics as aromatase inhibitors

Computational studies and structural insights for discovery of potential natural aromatase modulators for hormone-dependent breast cancer

Synthesis, In vitro and In silico Studies of Novel bis‐triazolopyridopyrimidines from Curcumin Analogues as Potential Aromatase Agents

Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors

Implant treatment with fixed prostheses in the edentulous maxilla. Part 1: implants and biologic response in two patient cohorts restored between 1986 and 1987 and 15 years later.

Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories.